322 related articles for article (PubMed ID: 19933848)
21. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.
Kawamura K; Izumi H; Ma Z; Ikeda R; Moriyama M; Tanaka T; Nojima T; Levin LS; Fujikawa-Yamamoto K; Suzuki K; Fukasawa K
Cancer Res; 2004 Jul; 64(14):4800-9. PubMed ID: 15256449
[TBL] [Abstract][Full Text] [Related]
22. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
[TBL] [Abstract][Full Text] [Related]
23. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
[TBL] [Abstract][Full Text] [Related]
24. P53, cyclin-dependent kinase and abnormal amplification of centrosomes.
Fukasawa K
Biochim Biophys Acta; 2008 Sep; 1786(1):15-23. PubMed ID: 18472015
[TBL] [Abstract][Full Text] [Related]
25. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.
Tarapore P; Shinmura K; Suzuki H; Tokuyama Y; Kim SH; Mayeda A; Fukasawa K
FEBS Lett; 2006 Jan; 580(2):399-409. PubMed ID: 16376875
[TBL] [Abstract][Full Text] [Related]
26. Mechanism limiting centrosome duplication to once per cell cycle.
Tsou MF; Stearns T
Nature; 2006 Aug; 442(7105):947-51. PubMed ID: 16862117
[TBL] [Abstract][Full Text] [Related]
27. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
Lingle WL; Lukasiewicz K; Salisbury JL
Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
[TBL] [Abstract][Full Text] [Related]
28. Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex.
Nishimura T; Takahashi M; Kim HS; Mukai H; Ono Y
Genes Cells; 2005 Jan; 10(1):75-86. PubMed ID: 15670215
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer.
Denu RA; Burkard ME
Sci Rep; 2020 Jul; 10(1):11921. PubMed ID: 32681070
[TBL] [Abstract][Full Text] [Related]
30. Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure.
Wang X; Wang RH; Li W; Xu X; Hollander MC; Fornace AJ; Deng CX
J Biol Chem; 2004 Jul; 279(28):29606-14. PubMed ID: 15123655
[TBL] [Abstract][Full Text] [Related]
31. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
D'Assoro AB; Busby R; Suino K; Delva E; Almodovar-Mercado GJ; Johnson H; Folk C; Farrugia DJ; Vasile V; Stivala F; Salisbury JL
Oncogene; 2004 May; 23(23):4068-75. PubMed ID: 15064746
[TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
[TBL] [Abstract][Full Text] [Related]
33. DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2.
Bourke E; Brown JA; Takeda S; Hochegger H; Morrison CG
Oncogene; 2010 Jan; 29(4):616-24. PubMed ID: 19838212
[TBL] [Abstract][Full Text] [Related]
34. Suppression of centrosome amplification after DNA damage depends on p27 accumulation.
Sugihara E; Kanai M; Saito S; Nitta T; Toyoshima H; Nakayama K; Nakayama KI; Fukasawa K; Schwab M; Saya H; Miwa M
Cancer Res; 2006 Apr; 66(8):4020-9. PubMed ID: 16618721
[TBL] [Abstract][Full Text] [Related]
35. CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells.
Chen Z; Liu X; Kawakami M; Liu X; Baker A; Bhatawadekar A; Tyutyunyk-Massey L; Narayan K; Dmitrovsky E
Cancer Biol Ther; 2023 Dec; 24(1):2279241. PubMed ID: 38031910
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of E2F3 results in centrosome amplification.
Saavedra HI; Maiti B; Timmers C; Altura R; Tokuyama Y; Fukasawa K; Leone G
Cancer Cell; 2003 Apr; 3(4):333-46. PubMed ID: 12726860
[TBL] [Abstract][Full Text] [Related]
37. Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.
Johnson KA; Tan M; Sütterlin C
Cell Microbiol; 2009 Jul; 11(7):1064-73. PubMed ID: 19290915
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1.
Oikawa T; Okuda M; Ma Z; Goorha R; Tsujimoto H; Inokuma H; Fukasawa K
Mol Cell Biol; 2005 May; 25(10):4046-61. PubMed ID: 15870277
[TBL] [Abstract][Full Text] [Related]
39. Abnormal centrosome amplification in the absence of p53.
Fukasawa K; Choi T; Kuriyama R; Rulong S; Vande Woude GF
Science; 1996 Mar; 271(5256):1744-7. PubMed ID: 8596939
[TBL] [Abstract][Full Text] [Related]
40. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Wang W; Budhu A; Forgues M; Wang XW
Nat Cell Biol; 2005 Aug; 7(8):823-30. PubMed ID: 16041368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
